Young Onset Asian Diabetes (Under 40 Years)

Metabolic Diseases
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

L
LabcorpNC - Burlington
1 program
Oral glucose tolerance test and HbA1cN/A1 trial
Active Trials
NCT07452159Not Yet Recruiting3,000Est. Jan 2029

Trial Timeline

Clinical trial activity over time

2026
2027
2028
2029
LabcorpOral glucose tolerance test and HbA1c

Clinical Trials (1)

Total enrollment: 3,000 patients across 1 trials

NCT07452159LabcorpOral glucose tolerance test and HbA1c

Diabetes In Asians at Risk in Youth

Start: Mar 2026Est. completion: Jan 20293,000 patients
N/ANot Yet Recruiting

Related Jobs in Metabolic Diseases

Principal Product Engineer

Medtronic
North Haven, Connecticut, United States of America
Yesterday
$120K - $180K/yr

Obesity Commercial Lead (Pre-Launch), ICO

Pfizer
United Kingdom - Walton Oaks; Europe - Any Pfizer Site
Yesterday

Vice President, Head of Financial Planning and Analysis

NewAmsterdam Pharma
Remote
Yesterday

Senior Medical Science Liaison - Obesity - CO, NE, AZ, NM, UT

Amgen
Colorado - Denver, US
2d ago

Senior Product Manager - Body Composition

GE HealthCare
Remote
2d ago
$150K - $224K/yr

Medical Science Liaison - Obesity - MN, IA, WI

Amgen
Minnesota - Minneapolis, US
2d ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Diabetes(750)Diabetes Mellitus, Type 2(556)Obesity(260)Type 2 Diabetes(216)Type 2 Diabetes Mellitus(211)Diabetes Mellitus(137)Diabetes Mellitus, Type 1(106)Type 1 Diabetes Mellitus(55)Type 1 Diabetes(53)Dyslipidemia(48)